Dr McShane talks about the University's work in creating an improved vaccine against tuberculosis and she also talks about the urgency of this research. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/
All content for Vaccine Research at Oxford is the property of Oxford University and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr McShane talks about the University's work in creating an improved vaccine against tuberculosis and she also talks about the urgency of this research. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/
Dr McShane talks about the University's work in creating an improved vaccine against tuberculosis and she also talks about the urgency of this research. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/
A talk about the University's work in China and Africa and its attempts to identify the key determinants of protective immunology against HIV infection that should guide future vaccine design. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/
Helen McShane and Dr Helen Fletcher talk about a new TB vaccine currently being developed at Oxford's Wellcome Trust Centre that could become a more effective vaccine against Tuberculosis. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/
Dr McShane talks about the University's work in creating an improved vaccine against tuberculosis and she also talks about the urgency of this research. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/
